FDA grants accelerated approval for first engineered T cell therapy to treat adults with synovial sarcoma

The U.S. Food and Drug Administration (FDA) has granted accelerated approval for the immunotherapy afamitresgene autoleuecel (Tecelra®, also known as afami-cel) for the treatment of adults with a rare soft tissue cancer called synovial sarcoma.

The secret to human brain’s learning efficiency revealed

Researchers from the MRC Brain Network Dynamics Unit and Oxford University’s Department of Computer Science have set out a new principle to explain how the

January 10, 2024

From Coma to Consciousness: Psychedelics’ Role According to National Geographic

The TDR Three Takeaways From National Geographic National Geographic, a traditionally conservative magazine, has published an informative feature on psychedelics this week. National Geographic examines

April 4, 2024

Eckert & Ziegler Again Increases Sales and Earnings Compared to Previous Year. Profit Forecast Raised for 2024. – Biotech Investments

Eckert & Ziegler SE / Key word(s): Half Year Results/Change in Forecast Eckert & Ziegler Again Increases Sales and Earnings Compared to Previous Year. Profit

July 17, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.